More on Hologic (HOLX): Company posts a mixed FQ2 report, beating on its EPS but missing on revenue. Net losses widened amid acquisition-related charges and other items which masked strong revenue growth. For the year, the company lowered its EPS estimate to between $1.54 to $1.56 on revenue of around $2.53B to $2.55B. For the current quarter, it now sees earnings of $0.36 to $0.37 on revenue of between $625M to $630M, below Street estimates for $0.41 on $655M, respectively. Shares -3% AH.